The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
This opens up a huge market for the company’s Magnezis implants in India
The company plans to expand its portfolio in regulated markets aggressively
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
The rates for over 400 procedures were revised
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines
Subscribe To Our Newsletter & Stay Updated
